Protocol Ledger

NCT03869892 · Phase III · ACTIVE NOT RECRUITING

Phase III Study in First-line Treatment of Patients With Metastatic Colorectal Cancer Who Are Not Candidate for Intensive Therapy.

Interventional Phase III clinical trial protocol NCT03869892 sponsored by Institut de Recherches Internationales Servier in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2019-03-21 Enrollment: 856 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT03869892
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)856 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)1 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT03869892
Protocol FieldVerified Registry Value
NCT IdentifierNCT03869892
Consolidated Lead SponsorInstitut de Recherches Internationales Servier
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase III
Overall Recruitment StatusACTIVE NOT RECRUITING
Registered Enrollment856 participants (ACTUAL)
Registered Start Date2019-03-21
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT03869892
Hospital Research SiteLocationSite Profile
Institut Sainte CatherineAvignon, FranceOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI